Does osteopathic treatments improve the symptoms of headache and/or head-pressure in patients with Chronic Rhinosinusitis (CRS)?

Similar documents
Design: Randomized controlled trial using a waiting list design.

Evaluation of the Change in Recent Diagnostic Criteria of Chronic Rhinosinusitis: A Cross-sectional Study

Chronic Rhinosinusitis-Treatment

Retrospective Analysis of Patients with Allergy Sinusitis

Original Article Comparison of different surgical approaches of functional endoscopic sinus surgery on patients with chronic rhinosinusitis

MANAGEMENT OF RHINOSINUSITIS IN ADULTS IN PRIMARY CARE

ROLE OF ANATOMICAL OBSTRUCTION IN THE PATHOGENESIS OF CHRONIC SINUSITIS

Treatment Options for Chronic Sinusitis

OSTEITIS IN CRS. Rhinology Chair Meeting presented by Amal Binhazza a

SINUSITIS/RHINOSINUSITIS

Maximum Medical Therapy of Chronic Rhinosinusitis. Riyadh Alhedaithy R5 ENT Resident, Combined KSUF and SB. 30/12/2015

Dose-dependent effects of tobramycin in an animal model of Pseudomonas sinusitis Am J Rhino Jul-Aug; 21(4):423-7

Rhinosinusitis. John Ramey, MD Joseph Russell, MD

Chronic Sinusitis. Acute Sinusitis. Sinusitis. Anatomy of the Paranasal Sinuses. Sinusitis. Medical Topics - Sinusitis

DURATION OF ORAL ANTIBIOTIC IN THE SETING OF MAXIMAL MEDICAL THERAPY FOR CHRONIC RHINOSINUSITIS. Dr. Ziyad Al-Abduljabbar

Functional Endoscopic Sinus Surgery (FESS)

9/18/2018. Disclosures. Objectives

Disclaimers. Topical Therapy. The Problem. Topical Therapy for Chronic Rhinosinusitis No Disclosures

MANAGEMENT OF RHINOSINUSITIS IN ADOLESCENTS AND ADULTS

European position paper on Rhinosinusitis & Nnasal Polyps 2012 (summary)

JMSCR Vol 05 Issue 10 Page October 2017

Functional Endoscopic Sinus Surgery

Reliability of computed tomography scans in the diagnosis of chronic rhinosinusitis

CHRONIC RHINOSINUSITIS IN ADULTS

TUEC Guidelines Medical Information to Support the Decisions of TUE Committees Sinusitis/Rhinosinusitis SINUSITIS/RHINOSINUSITIS

Eosinophilic Rhinosinusitis is Not a Disease of Ostiomeatal Occlusion

FUNCTIONAL ENDOSCOPIC SINUS SURGERY (FESS)

A comparative analysis of CT scan versus diagnostic nasal endoscopy in chronic rhino sinusitis

FUNCTIONAL ENDOSCOPIC SINUS SURGERY (FESS)

US Drug Eluting Sinus Stent (DESS) Market: Size, Trends & Forecasts ( ) September 2016

DIFFICULT-TO-TREAT CHRONIC

An Innovative Treatment Option for Patients with Recurrent Nasal Polyps

SINUSITIS. HAVAS ENT CLINICS Excellence in otolaryngology

If looking for a book by Norra MacReady The patient with a sinus headache may actually have a migraine.(more than 3,000 Patients Studied): An article

FUNCTIONAL ENDOSCOPIC SINUS SURGERY (FESS)

We are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists. International authors and editors

National Imaging Associates, Inc. Clinical guidelines/considerations SINUS & MAXILLOFACIAL AREA CT 70486, 70487, 70488

Dr.Adel A. Al Ibraheem

MEDICAL POLICY I. POLICY FUNCTIONAL ENDOSCOPIC SINUS SURGERY FOR CHRONIC RHINOSINUSITIS MP POLICY TITLE POLICY NUMBER

Quality of life after functional endoscopic sinus surgery in patients with chronic rhinosinusitis

The ROLE OF ALPHINTERN IN TREATMENT OF NASAL POLYPOSIS

Kate Coursey. Designing an outcomes-based study of disability, depression, and patient satisfaction for patients. with chronic rhinosinusitis

Derriford Hospital. Peninsula Medical School

Incidence of accessory ostia in patients with chronic maxillary sinusitis

Rhinosinusitis: An Anatomic Study of Maximal Medical Therapy

A comprehensive study on complications of endoscopic sinus surgery

Risk Factors of Chronic Rhinosinusitis After Functional Endoscopic Sinus Surgery

Phototherapy in Allergic Rhinitis

If looking for a ebook by Norra MacReady The patient with a sinus headache may actually have a migraine.(more than 3,000 Patients Studied): An

ORIGINAL ARTICLE. The Impact of Sinus Computed Tomography on Treatment Decisions for Chronic Sinusitis. widespread condition, affecting

Treatment & Management of Acute Sinusitis in the Primary Care Setting

ISSN X (Print) Research Article. *Corresponding author Dr.V. Krishna Chaitanya

Sinonasal Irrigation using Ceftriaxone-Saline Solution ameliorates Chronic Rhinosinusitis Clinical Severity and Improves Patients Quality of Life

thus, the correct terminology is now rhinosinusitis.

JMSCR Vol 04 Issue 05 Page May 2016

International Journal of Research and Review E-ISSN: ; P-ISSN:

FOR CMS (MEDICARE) MEMBERS ONLY NATIONAL COVERAGE DETERMINATION (NCD) FOR COMPUTED TOMOGRAPHY:

ORIGINAL ARTICLE. Trends in Endoscopic Sinus Surgery Rates in the Medicare Population

NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE

CLINICAL PROFILE OF CHRONIC RHINO SINUSITIS AND POLYPOSIS- EXPERIENCED IN GOVERNMENT TERTIARY CARE HOSPITAL

Allergic fungal rhinosinusitis a new staging system*

Recalcitrant chronic rhinosinusitis. Difficulties in diagnosis and treatment Videler, W.J.M.

Clinical Policy Title: Propel (drug eluting devices after sinus surgery)

Implantable Sinus Stents for Postoperative Use Following Endoscopic Sinus Surgery

Clinical Policy Title: Propel (drug eluting devices after sinus surgery)

Sinusitis & its complication. MOHAMMED ALESSA MBBS,FRCSC Assistant Professor,Consultant Otolaryngology, Head & Neck Surgery King Saud University

Pediatric Imaging Spine MRI and Spine CT Test Request Tip Sheet

Tomographical Findings in Adult Patients Undergoing Endoscopic Sinus Surgery Revision

White Paper: Balloon Sinuplasty for Chronic Sinusitis, The Latest Recommendations

Implantable Sinus Stents for Postoperative Use Following Endoscopic Sinus Surgery

Protocol. Implantable Sinus Stents for Postoperative Use Following Endoscopic Sinus Surgery and for Recurrent Sinus Disease

Delivering Innovation. Where It s Needed. August 2018

Middleton Chapter 43 (pages ) Rhinosinusitis and Nasal Polyps Prepared by: Malika Gupta, MD

The role of plain radiographs in the diagnosis of chronic maxillary rhinosinusitis in adults

Implantable Sinus Stents for Postoperative Use Following Endoscopic Sinus Surgery and for Recurrent Sinonasal Polyposis

How Effective is Acupuncture in Treating Persistent Allergic Rhinitis in Children and Adults?

2017 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Efficiency

2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY

Latest advances in the management of childhood allergic rhinitis

Conventional Sinus Surgery Vs Fess

FUNCTIONAL ENDOSCOPIC SINUS SURGERY (FESS)

Section Editor Mark D Aronson, MD

Congestion, headache, recurrent infection, post-nasal drip, smell problems? We can find the source and offer solutions for relief.

NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE

Spine MRI and Spine CT Test Request Tip Sheet

Implantable Sinus Stents for Postoperative Use Following Endoscopic Sinus Surgery and for Recurrent Sinus Disease

Management of rhinosinusitis: an evidence based approach

FUNCTIONAL ENDOSCOPIC SINUS SURGERY (FESS)

Pediatric Imaging Spine MRI and Spine CT Test Request Tip Sheet

Chronic rhinosinusitis (CRS) is an inflammatory disorder of the

ORIGINAL ARTICLE. Computed Tomographic Staging and the Fate of the Dependent Sinuses in Revision Endoscopic Sinus Surgery

Functional endoscopic sinus surgery (FESS) is an effective

Osteopathy today. 9 th International Congress of the German Osteopathic Association (VOD)

Spine MRI and Spine CT Test Request Tip Sheet

Pharmacoeconomics of Cyclamen europaeum in the Management of Acute Rhinosinusitis

Management of chronic rhinosinusitis

7th International Workshop on Endoscopic Sinus Surgery

Lost to Follow-Up: Chronic Rhinosinusitis. Jacob Burdett, OMSIII

The prevalence of positive fungal cultures in patients with chronic rhinosinusitis in a high altitude region of Iran

Transcription:

Does osteopathic treatments improve the symptoms of headache and/or head-pressure in patients with Chronic Rhinosinusitis (CRS)? A randomized controlled trial Roos S 1, Steinbauer U 1, Amann P 1, Schwerla F 2, Resch KL 3 1 COE - European College of Osteopathy, Germany 2 German Academy of Osteopathy (AFO), Research Commission 3 German Institute for Health Research (DIG)

Background CRS is one of the most widespread chronic diseases. Inflammations of the mucosa of the nose as well as of the paranasal sinus are among the 3 most frequent human diseases.

Present therapy of CRS Drug therapy: Antibiotics, Corticosteroids, Antihistamines, etc. Surgical therapy: Functional endoscopic surgery of paranasal sinus (FESS) Alternative therapies: Herbal compounds Acupuncture treatment Nasal saline irrigation

Objective Primary question Do osteopathic treatments improve the intensity and frequency of headache and/or the head-pressure in patients with Chronic Rhinosinusitis (CRS)? Secondary question Do osteopathic treatments improve the symptomatic of CRS as a whole?

Study design I The appropriate choice of the study design always depends on the objective being investigated When proving an effect of an intervention today, the randomized controlled trial (RCT) is the gold standard For the chosen objective the effectiveness of an osteopathic treatment should be assessed: a pragmatic trial (versus the efficacy and an explanatory trial) For an appropriate sham-treatment the mode of action of the index treatment has to be known

Study design II Standard intervention: Evidence of Efficacy? NO YES New effective? NEW vs. UNTREATED New efficacious? NEW vs. PLACEBO (SHAM) New intervention: Evidence of Effectiveness? The choice of the control group Prof. Dr. K.L. Resch, personal communication, 2007 NO YES New effective? STANDARD + NEW vs. STANDARD New better? NEW vs. STANDARD

Study design III Randomized controlled trial with follow up four months after end of treatments Two groups: Intervention group: 5 osteopathic treatments at two week intervals Control group: untreated control group for 10 weeks ( waiting-list-design ). Consecutively 5 osteopathic treatments

Eligibility criteria Inclusion criteria: minimum age of 18 years diagnosed CRS by a physician headache/ head pressure for > 1 year headache or head-pressure above the level of 3 on the numeric-rating scale (NRS) from 0-10 Exclusion criteria: due to the profession (e.g. varnisher, chemistry) seasonal (hay fever, allergy to pollen) systemic disease (e.g. asthma) migraine

Outcome measures Primary outcome measure The intensity and frequency of headache and/or head pressure subjectively felt by the patient. Measuring instrument: Numeric rating scale (NRS) 0-10 Secondary outcome measure Total pathology of CRS Measuring instrument: Sinonasal assessment questionnaire (SNAQ-11)

Osteopathic findings and intervention Osteopathic findings cranial standardized record of findings visceral standardized record of findings parietal black-box-examination Evaluation system of the dysfunctions 0 = not affected/ full mobility 1 = slightly affected / limited mobility 2 = strongly affected / blocked Intervention Osteopathic treatment, specific to the individual findings of the patient

CONTROL GROUP OSTEOPATHIE GROUP Time table Period in Weeks Time points T1 T2 T3 T4 T5 T6 T7 T8 T9 T10 T11 0 2 4 6 8 10 12 14 16 18 20 Feb 2006 Scan of the NRS and/or SNAQ O O O O O O O Treatment X X X X X Treatment X X X X X Time of waiting Scan of the NRS and /or SNAQ Period in Weeks O O O O O O O O O O O 0 2 4 6 8 10 12 14 16 18 20 Feb >32 2006 O 1. Follow-Up O 2. Follow-Up

Flow chart 101 patients assessed for eligibility 40 patients excluded 61 patients randomized 31 patient allocated to osteopathic treatment group 31 analyzed data 1. Follow-Up (n=31) 30 patients allocated to waiting list group 29 analyzed data (1 drop out) 26 patients treated in the waiting list group (3 drop outs) 1. Follow-Up (n=26) 2. Follow-Up (n=57) 51 complete data

Base-line characteristics Intervention group (n=31) Mean ± SD Control group (n=29) Mean ± SD p-value age 44.8 ± 12.8 42.1 ± 12.5 0.420 gender men 12 3 women 19 26 Duration (years) 14.1 ± 12.2 11.0 ± 7.9 0.253 actual headache (NRS) 3.1 ± 2.6 3.2 ± 2.6 0.928 actual head-pressure (NRS) 3.7 ± 2.5 4.2 ± 2.3 0.817 SNAQ-11 71.1 ± 22.4 65.2 ± 24.9 0.551

Results Inter-group differences (NRS-Scores) actual headache intensity actual headpressure Frequency of headache Frequency of head-pressure Longitudinal changes T1 to T5 Control group (n=29) Osteopathic group (n=31) Betweengroup difference, and 95 % CI -0.2 1.5 1.7 (-0.1 to -3.2) -0.2 1.6 1.8 (-0.3 to -3.3) -0.4 2.6 3.0 (-1.2 to -4.8) -0.1 3.0 3.1 (-1.3 to -4.8) p - value 0.039 0.002 0.001 0.001

Results Within-group longitudinal changes (NRS-Scores) Begin of treatment (T1) End of treatment (T5) Intra-group difference, and 95% CI p - value Actual headache Osteopathic group Control group 3.2 3.2 1.7 3.4 1.5 (0.4 to 2.6) -0.2 (1.0 to -1.3) 0.011 0.760 Actual head pressure Osteopathic group Control group 3.7 4.2 2.1 4.4 1.6 (0.6 to 2.6) -0.2 (1.0 to -0.4) 0.002 0.682 Frequency headache Osteopathic group Control group 5.6 4.3 3.0 4.7 2.6 (1.5 to 3.7) -0.4 (-1.9 to 1.1) <0.001 0.601 Frequency pressure Osteopathic group Control group 6.2 6.4 3.2 6.5 3.0 (1.7 to 4.2) -0.1 (-1.3 to 1.2) <0.001 0.956

Results Analysis of the relevant disorders Time dependent comparison within the groups Intensity Frequency 8 8 7 7 control group 6 5 4 3 2 Osteopathic group control group Warteliste Osteopathie 6 5 4 3 2 Osteopathic group Warteliste Osteopathie 1 1 0 T1 T2 T3 T4 T5 Osteopathic group: improvement 55% Control group: Worsening 2% 0 T1 T2 T3 T4 T5 Osteopathic group: improvement 57% Control group: Improvement 6%

Results Secondary parameters SNAQ-11: Total symptomatic of CRS, within group longitudinal changes Begin of treatment (T1) End of treatment (T5) Intra-group difference, and 95% CI p - value Osteopathic group Control group 71.2 65.2 34.9 52.1 36.3 (27.1 to 45.5) 13.1 (-1.5 to 27.7) <0.001 0.076 Improvement in the osteopathic group: 51% Osteopathic dysfunctions: - Structures of the paranasal sinuses most frequently involved (e.g. Maxilla, Os ethmoidale, Os frontale, Os sphenoidale and Os occipitale) - Visceral and parietal findings much less

Results Analysis of reproducibility and sustainability of the trial 75 70 65 60 55 50 45 40 35 30 25 20 15 Waiting list group Osteopathic group 10 Studieneintritt Begin Behandlungsende End 1. Follow-Up first second 2. Follow-Up of treatment Follow-up SNAQ-11: Total symptomatic of CRS Osteopathic Osteopathie group (n=27) Warteliste Treatment of the waiting gro up Begin End First Followup Second Followup 71.2 34.9 31.5 32.6 66.1 40.7 35.4 37.1 First Follow-up: 4 weeks after the last treatment of each patient Second Follow-up: about 2.5 years from the begin of the study

Conclusion Five osteopathic treatments within an eight-week period seam to have caused a clinically relevant relieve of the overall symptomatology and of pain in CRS. The positive evidence for the effectiveness of osteopathic treatments for patients with CRS found by this study is promising.

Acknowledgement We thank the organizing committee for inviting us to this Conference. We thank the German Association of Osteopaths (VOD) for financial support.

Thank you for your attention Email: f.schwerla@german-afo.de References: Benninger MS, Ferguson BJ, Hadley JA, Hamilos DL, Jacobs M, Kennedy DW, Lanza DC, Marple BF, Osguthorpe JD, Stankiewicz JA, Anon J, Denneny J, Emanuel I, Levine H. Adult chronic rhino-sinusitis: definitions, diagnosis, epidemiology, and pathophysiology. Otolaryngol Head Neck Surg. 2003 Sep;129(3 Suppl):S1-32. Cherry WB, Li JT. Chronic rhinosinusitis in adults. Am J Med. 2008 Mar;121(3):185-9. Harvey R, Hannan SA, Badia L, Scadding G. Nasal saline irrigations for the symptoms of chronic rhino-sinusitis. Cochrane Database of Systematic Reviews 2007, Issue 3 Kalish LH, Arendts G, Sacks R, Craig JC. Topical steroids in chronic rhino-sinusitis without polyps: a systematic review and meta-analysis. Otolaryngol Head Neck Surg. 2009 Dec;141(6): 674-83. Khalil H, Nunez DA. Functional endoscopic sinus surgery for chronic rhino-sinusitis. Cochrane Database of Systematic Reviews 2006, Issue 3, updated 2008 Lund VJ. Maximal medical therapy for chronic rhino-sinusitis. Otolaryngol Clin North Am. 2005 Dec; 38 (6):1301-10,

Ergebnisse Quantitative Analyse der osteopathischen Dysfunktionen Mittelwerte 45 40 35 30 25 20 15 10 5 0 Paranasale Strukturen Restliches Cranium Viszerum Summe der Bewertungen (0/1/2) der gefundenen Dysfunktionen (n=57, Mittelwerte, Skala= 0 bis 114)